SN Compr Clin Med
Key findings from OASIS 4: Patients taking the oral semaglutide 25 mg pill lost an average of 13.6% of body weight versus 2.4% for placebo, when looking at all participants regardless of whether they stayed on treatment Among patients who completed the full course, average weight loss reached 16.6% , compared to 2.7% with placebo More than one-third of adherent participants lost 20% or more of their body weight 76% of patients on the pill lost at least 5% of body weight, versus 31% on placebo Participants also showed improvements in blood pressure, waist circumference, LDL cholesterol, and triglycerides Serious adverse events were actually less frequent with oral semaglutide than placebo (3.9% vs
350
Glutathione neutralizes free radicals, protecting cells from damage
Lee MJ, Koff JL, Leautaud V, Hildebrandt MAT , Morin RD, Flowers CR
Because of this unpredictability, healthcare providers must remain vigilant when prescribing alongside GLP-1 agents